Testing effectiveness (Phase 2)UnknownNCT04507477
What this trial is testing
Ex-vivo Delivery of Rituximab to Prevent PTLD in EBV Mismatch Lung Transplant Recipients: A Pilot Trial
Who this might be right for
Epstein-Barr Virus InfectionsPost-transplant Lymphoproliferative Disorder
University Health Network, Toronto 10